Pathology News
admin

About admin@pathologynews.com

This author has not yet filled in any details.
So far admin@pathologynews.com has created 1089 blog entries.

May 2024

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395

2024-05-28T09:34:21+00:00

Owkin, the first end-to-end TechBio unicorn that uses cutting-edge causal AI to unlock precision drug discovery, development and diagnostics, has unveiled an innovative drug pipeline in oncology and immunology following an exclusive global licensing agreement with Idorsia (SIX: IDIA) to develop and commercialize OKN4395, a clinic-ready best-in-class dual inhibitor of prostanoid receptors EP2 and EP4.

Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN43952024-05-28T09:34:21+00:00

PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions

2024-05-24T10:45:42+00:00

Joint Offering Empowers Biopharma with Unique Datasets for Discovery of Novel Oncology Research Insights

PathAI and Aster Insights Partner to Deliver Combined AI-Derived Structured Pathology and Multimodal Real-World Data Solutions2024-05-24T10:45:42+00:00

Digital Pathology Implementation: Insights From Experts at DP&AI: USA

2024-05-24T10:04:18+00:00

The reports provide a comprehensive overview of the digital pathology implementation experiences at the University of Michigan and Mayo Clinic, showcasing the benefits, challenges, and future potential of digital and AI technologies in pathology.

Digital Pathology Implementation: Insights From Experts at DP&AI: USA2024-05-24T10:04:18+00:00

Indica Labs Receives FDA Clearance For HALO AP Dx Digital Pathology Platform For Use With Hamamatsu Images Acquired With The Nanozoomer® S360MD Slide Scanner

2024-05-23T08:12:24+00:00

Indica Labs, an industry leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announce that the U.S. Food and Drug Administration (FDA) has issued a 510(k) clearance to Indica Labs for HALO AP Dx, an enterprise digital pathology platform. HALO AP Dx is indicated for primary diagnosis of surgical pathology slides prepared from formalin-fixed paraffin embedded (FFPE) tissue scanned by the NanoZoomer® S360MD Slide scanner¹. This 510(k) clearance from the FDA expands on an established partnership between Indica Labs and Hamamatsu Photonics K.K.

Indica Labs Receives FDA Clearance For HALO AP Dx Digital Pathology Platform For Use With Hamamatsu Images Acquired With The Nanozoomer® S360MD Slide Scanner2024-05-23T08:12:24+00:00

Aiosyn And Histowiz Partner To Improve Kidney Disease Research Through AI-powered Preclinical Studies

2024-05-22T13:21:59+00:00

Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for cancer and kidney disease, and HistoWiz, a leading provider of histology and slide archiving services, today announced a pilot study to evaluate the benefits of integrating Aiosyn’s NephroPath kidney analysis algorithms onto HistoWiz’s PathologyMap™ digital pathology platform. This collaboration aims to advance kidney pathology analysis and research, by allowing PathologyMap users direct access to NephroPath algorithms without any additional software.

Aiosyn And Histowiz Partner To Improve Kidney Disease Research Through AI-powered Preclinical Studies2024-05-22T13:21:59+00:00

PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe

2024-05-22T11:56:56+00:00

AISight IMS enables pathology labs to be at the forefront of emerging and state-of-the-art digital pathology technologies and workflows.

PathAI Announces Early Access Program to Drive Adoption of AISight Image Management System in Anatomic Pathology Laboratories Across Mainland Europe2024-05-22T11:56:56+00:00

Deep Bio Unveils Research Findings on Performance Evaluation of AI Algorithm for Breast Cancer Analysis

2024-05-22T10:59:05+00:00

Deep Bio utilizes deep learning-based algorithms to differentiate breast cancer lesions accurately, optimizing diagnostic accuracy.

Deep Bio Unveils Research Findings on Performance Evaluation of AI Algorithm for Breast Cancer Analysis2024-05-22T10:59:05+00:00

Case Study: Bedfordshire Hospitals NHS Foundation Trust Partnership With Diagnexia

2024-05-21T07:28:50+00:00

Bedfordshire Hospital NHSFT, working against the challenges of increased case complexity and COVID-19 impacts, sought Diagnexia’s off-site histopathology reporting services to improve turnaround times for diagnostic reports.

Case Study: Bedfordshire Hospitals NHS Foundation Trust Partnership With Diagnexia2024-05-21T07:28:50+00:00

Highlights from the 10th Digital Pathology & AI Congress: USA

2024-05-20T10:57:00+00:00

Pathology News is pleased to bring you a report on the Digital Pathology & AI Congress: USA, a landmark event highlighting the forefront of digital innovation in digital pathology. In this initial article, we introduce the meeting, offer an overview of the latest developments and insights, let you know what’s to come from this series and offer a preview of the report’s key highlights.

Highlights from the 10th Digital Pathology & AI Congress: USA2024-05-20T10:57:00+00:00

A Short Overview Of The History Of Pathology: Origins, Early Days, And The Transition To Novel Technologies

2024-05-17T09:01:20+00:00

Throughout history, pathology has remained an integral component of medicine, tracing its origins to ancient healers recognizing the importance of understanding disease processes for effective treatments. What began as speculative observations has since evolved into a complex specialty characterized by precise assessments, predictive diagnosis, and advanced imaging modalities. This transformation has been driven by technological advances that have revolutionized this field time and time again.

A Short Overview Of The History Of Pathology: Origins, Early Days, And The Transition To Novel Technologies2024-05-17T09:01:20+00:00
Go to Top